These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7195531)

  • 1. Determination of ovarian function using first morning urine steroid assays.
    Denari JH; Farinati Z; Casas PR; Oliva A
    Obstet Gynecol; 1981 Jul; 58(1):5-9. PubMed ID: 7195531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prediction and/or detection of ovulation by means of urinary steroid assays.
    Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
    Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
    Stanczyk FZ; Miyakawa I; Goebelsmann U
    Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct assay of urinary steroid glucuronides for monitoring the approach of ovulation.
    Merlo AB; Farinati Z; Quiroga S; Nagle CA; Carril LM; Lahoz M; Mendizabal AF
    Int J Fertil; 1984; 29(3):189-93. PubMed ID: 6152260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
    Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
    Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of ovarian follicle size and the urinary excretion of oestrone glucuronide, luteinizing hormone and pregnanediol glucuronide in spontaneous cycles.
    Adekunle AO; Collins WP; Whitehead MI
    Afr J Med Med Sci; 1988 Jun; 17(2):77-82. PubMed ID: 2843021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of estrone-3-glucuronide and pregnanediol-3 alpha-glucuronide in early morning urine samples to monitor ovarian function.
    Magini A; Pinzani P; Bolelli GF; Bassi F; Salerno R; Messeri G; Pazzagli M
    J Biolumin Chemilumin; 1989 Jul; 4(1):567-74. PubMed ID: 2801241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The random urine estrogen, pregnanediol/creatinine ratio determinations for monitoring ovarian function].
    Morimoto N; Noda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Mar; 36(3):347-53. PubMed ID: 6715918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between plasma estradiol and estrone-3-glucuronide in urine during the monitoring of ovarian induction therapy.
    Catalan R; Castellanos JM; Palomino T; Senti M; Antolin M; Galard RM
    Int J Fertil; 1989; 34(4):271-5. PubMed ID: 2570765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the time of ovulation in chimpanzees by measurement of LH, estrone sulfate, and pregnanediol 3 alpha-glucuronide in urine: comparison with serum hormone patterns.
    Steinetz BG; Ducrot C; Randolph C; Mahoney CJ
    J Med Primatol; 1992 Jul; 21(5):239-45. PubMed ID: 1404332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of glucuronometabolites of 17 beta-estradiol and progesterone in early morning urine samples: a promising new method for the evaluation of hormonal responses of Buserelin-hMG treatment in an IVF program.
    Pellegrini S; Rapi S; Coccia E; Pieri A; Mannelli M; Buzzoni P
    Acta Eur Fertil; 1989; 20(4):203-9. PubMed ID: 2519572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enzymatic determination of urinary estrone and estradiol: correlations with plasma estradiol in the menstrual cycle in women].
    Nicolas JC; Chikhaoui Y; Bressot N; Bornadet A; Descomps B; Cristol P; Hedon B
    J Gynecol Obstet Biol Reprod (Paris); 1982; 11(4):477-81. PubMed ID: 7142668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary beta-FSH subunit concentrations in perimenopausal and postmenopausal women: a biomarker for ovarian reserve.
    Liu JH; Kao L; Rebar RW; Muse K
    Menopause; 2003; 10(6):526-33. PubMed ID: 14627861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective multicentre study to develop universal immunochemical tests for predicting the fertile period in women. World Health Organisation Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
    Int J Fertil; 1985; 30(3):18-30. PubMed ID: 2867054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotrophin and steroid interrelationships during the normal menstrual cycle.
    Bell ET; Christie DW
    Steroidologia; 1970; 1(3):152-74. PubMed ID: 4940024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing.
    Blackwell LF; Vigil P; Gross B; d'Arcangues C; Cooke DG; Brown JB
    Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The measurement of urinary steroid glucuronides as indices of the fertile period in women. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, special programme of research, development and research training in human reproduction.
    Adlercreutz H; Brown J; Collins W; Goebelsman U; Kellie A; Campbell H; Spieler J; Braissand G
    J Steroid Biochem; 1982 Dec; 17(6):695-702. PubMed ID: 7176659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of small doses of progesterone released from two types of vaginal rings on ovarian activity and bleeding patterns during the first postpartum year.
    Landgren BM; Jonsson B; Cekan SZ
    Contraception; 1995 Apr; 51(4):255-60. PubMed ID: 7796592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary progesterone and pregnanediol. Use for monitoring progesterone treatment.
    Stanczyk FZ; Gentzschein E; Ary BA; Kojima T; Ziogas A; Lobo RA
    J Reprod Med; 1997 Apr; 42(4):216-22. PubMed ID: 9131494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.